Streetbeat News

Analyst Ratings

TPH

Analysts have provided somewhat bullish ratings for Tri Pointe Homes (NYSE:TPH) in the last quarter, with an average price target of $35.5, implying an upside from the current price of $29.895. The average price target has increased by 20.34% over the past month.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:00 pm

VRNT

Verint Systems Inc reported worse-than-expected earnings, leading to a drop in its share price. Several analysts have also cut their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:57 pm

PII

Baird analyst Craig Kennison has reiterated an Outperform rating on Polaris (NYSE:PII) and maintained a price target of $140.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:56 pm

CTLP

Barrington Research analyst Gary Prestopino has reiterated an Outperform rating on Cantaloupe (NASDAQ:CTLP) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:55 pm

DBI

Telsey Advisory Group has reiterated its 'Market Perform' rating on Designer Brands (NYSE:DBI) and maintained its price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:53 pm

GIII

Telsey Advisory Group has reiterated its 'Market Perform' rating on G-III Apparel Group (NASDAQ:GIII) and maintained its $22 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:52 pm

CBAY

HC Wainwright & Co. analyst Ed Arce has reiterated a 'Buy' rating on CymaBay Therapeutics (NASDAQ:CBAY) and maintained a price target of $21.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:51 pm

FMC

Blue Orca Capital has shorted FMC Corporation due to the company's alleged concealment of legal defeats that have allowed competitors to sell generic versions of FMC's flagship insecticide at significantly lower prices. FMC, an agricultural chemical manufacturer, has claimed that it will not face generic competition until 2026 due to its process patents. However, Blue Orca's investigation found that generic versions of FMC's top-selling insecticide are already being sold in key markets like India and China. The report also highlights FMC's increasing balance of receivables, customer defaults, and bankruptcies, and the company's decision to factor receivables at increasingly punitive rates.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:51 pm

VALN

HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Valneva (NASDAQ:VALN) and maintained a $22 price target.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:50 pm

BA

Boeing's CFO has reaffirmed the company's 2023 Free Cash Flow (FCF) goal, stating that recovery from recent quality issues will be 'lumpy not linear'. The AFT Pressure Bulkhead issue is expected to impact 75% of the 220 inventory 737s.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:37 pm